会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • Implantable therapy system
    • AU2014201907B2
    • 2015-06-18
    • AU2014201907
    • 2014-04-02
    • ENTEROMEDICS INC
    • DONDERS ADRIANUS PWEIJAND KOEN JLAMBERT SCOTT ANTHONYSPAR GREGORY PATSTULTZ MARK RAYMONDVALLAPUREDDY VINEELLAUGHLIN JOHN CHARLES
    • A61N1/36A61N1/372
    • Abstract A system for applying therapy to an internal anatomical feature of a body of a patient comprising, an external component including an external antenna configured to be placed 5 above a skin layer of a patient, the external component including a memory configured to store therapy programs and therapy schedules, the external component also including a user interface configured to receive input from a user and to display output to the user, the input including a selection of one of the therapy programs and one of the therapy schedules and an implantable component for placement in the body of the patient beneath 10 the skin layer, the implantable component including an implanted antenna configured to communicate with the external antenna across the skin layer through radiofrequency communication, the implantable component being configured to receive the selected therapy program and the selected therapy schedule from the external component via the external and implanted antennas, the implantable component being adapted to be 15 selectively configured into one of a training mode, a placebo mode, and a delivery mode, the implantable component being configured to apply therapy to the internal anatomical feature in accordance with the selected therapy program and the selected therapy schedule when configured in the delivery mode, and the implantable component being configured to refrain from generating electrical therapy signals when configured in the 20 training mode, and the implantable component being configured to supply therapy signals to a resistor located within the implantable component to drain an internal power source of the implantable component when configured in the placebo mode, wherein an external charger interacts with the patient as if therapy is being applied when the therapy signals are applied to the resistor during the placebo mode. 52587751 (GHMalters) P82937AU I
    • 4. 发明专利
    • Implantable therapy system
    • AU2014201907A1
    • 2014-04-17
    • AU2014201907
    • 2014-04-02
    • ENTEROMEDICS INC
    • DONDERS ADRIANUS PWEIJAND KOEN JLAMBERT SCOTT ANTHONYSPAR GREGORY PATSTULTZ MARK RAYMONDVALLAPUREDDY VINEELLAUGHLIN JOHN CHARLES
    • A61N1/36A61N1/372
    • Abstract A system for applying therapy to an internal anatomical feature of a body of a patient comprising, an external component including an external antenna configured to be placed 5 above a skin layer of a patient, the external component including a memory configured to store therapy programs and therapy schedules, the external component also including a user interface configured to receive input from a user and to display output to the user, the input including a selection of one of the therapy programs and one of the therapy schedules and an implantable component for placement in the body of the patient beneath 10 the skin layer, the implantable component including an implanted antenna configured to communicate with the external antenna across the skin layer through radiofrequency communication, the implantable component being configured to receive the selected therapy program and the selected therapy schedule from the external component via the external and implanted antennas, the implantable component being adapted to be 15 selectively configured into one of a training mode, a placebo mode, and a delivery mode, the implantable component being configured to apply therapy to the internal anatomical feature in accordance with the selected therapy program and the selected therapy schedule when configured in the delivery mode, and the implantable component being configured to refrain from generating electrical therapy signals when configured in the 20 training mode, and the implantable component being configured to supply therapy signals to a resistor located within the implantable component to drain an internal power source of the implantable component when configured in the placebo mode, wherein an external charger interacts with the patient as if therapy is being applied when the therapy signals are applied to the resistor during the placebo mode. 52587751 (GHMalters) P82937AU I